Skip to main content
HR 2541 119th Congress House Health

Nuclear Medicine Clarification Act of 2025

Introduced: June 20, 2025 Introduced by: Davis, Donald G. Democratic · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 1, 2025
Referred to the House Committee on Energy and Commerce.
Apr 1, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Nuclear Medicine Clarification Act of 2025

This bill requires the Nuclear Regulatory Commission (NRC) to revise its regulations so that health care providers must report to the NRC when a dose of a radioactive drug caused by an extravasation exceeds specified quantities. An extravasation generally means the unintentional presence of a radioactive drug in the tissue surrounding the blood vessel following an injection.

Under the NRC’s current regulations, health care providers licensed by the NRC to use radioactive materials must submit a report to the NRC for any instance, known as a medical event, where the administered dose of a radioactive drug exceeds specified quantities or criteria. 

In 2024, the NRC published a draft proposed rule that would add an extravasation as a medical event that must be reported. The draft proposed rule’s reporting threshold is based on a physician’s determination that the administration results or may potentially result in a radiation injury from an extravasation. The reporting threshold proposed by the NRC does not contain a quantified dose.

The bill requires the NRC to revise its regulations to add an extravasation as a medical event that must be reported, and it additionally requires the reporting threshold to be based on quantified doses (as specified in the bill).

What's happening now April 1, 2025

Referred to the House Committee on Energy and Commerce.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 13

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 13 filings →
 Cosponsors 8
All 8 Democratic 3 Republican 5
D
Carbajal, Salud O.
California · Aug 26, 2025
 D
Foushee, Valerie P.
North Carolina · Jun 20, 2025
 R
McCormick, Richard
Georgia · Jun 20, 2025
 D
Ross, Deborah K.
North Carolina · Jun 20, 2025
 R
Rutherford, John H.
Florida · Jun 20, 2025
 R
Fitzpatrick, Brian K.
Pennsylvania · Apr 10, 2025
 R
Cline, Ben
Virginia · Apr 1, 2025
 R
Griffith, H. Morgan
Virginia · Apr 1, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2541: Nuclear Medicine Clarification Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-2541/
MLA
"H.R. 2541: Nuclear Medicine Clarification Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-2541/.
Bluebook (legal)
H.R. 2541, 119th Cong. (2026), https://openamerica.io/bill/119-HR-2541/.
Markdown link
[H.R. 2541: Nuclear Medicine Clarification Act of 2025](https://openamerica.io/bill/119-HR-2541/)
Report a problem